Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
2022 · Nature Communications · 142 citations
https://doi.org/10.1038/s41467-022-28905-5
G
Gilad Halpert
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.8K
Citations
17
h-index
24
i10-index
Gilad Halpert is an academic researcher from Reichman University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Diabetes and associated disorders. The author has an h-index of 17, co-authored 51 publications.
ORCID: 0000-0002-5610-7347Papers by this author
worksAutoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023
2023 · Autoimmunity Reviews · 99 citations
https://doi.org/10.1016/j.autrev.2023.103287
Integrative Systems Immunology Analysis Reveals Elevated Anti-AGTR1 Levels with Accumulating COVID-19 Symptoms
2024 · medRxiv · 0 citations
https://doi.org/10.1101/2024.04.05.24305287
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat